Breaking News

You are here » Indian-Commodity  :  Commodities  :  Copper  :  Copper futures end lower on Monday

04-Oct2016

Copper futures end lower on Monday

Copper futures ended lower on Monday on account of funds sell off in global markets, though some losses were capped by expectations of firmer demand in world's top consumer China after improving economic data. Reports out on Saturday showed that activity in China's manufacturing sector expanded for a second month in a row in September.

Copper futures for December delivery fell 0.8 percent to settle at $2.192 a pound on the Comex metals division of New York Mercantile Exchange. While, copper on the London Metal Exchange ended down 0.9 percent to $4,819 a metric ton.


Related News

View all news

Copper futures end lower on Thursday

Copper futures ended lower on Thursday, following Chinese stock markets lower on the prospect of slowing global economic growth. Further, concerns over US interest rates and the US-China trade war too......

Copper futures end lower on Thursday

Copper futures ended lower on Thursday, following Chinese stock markets lower on the prospect of slowing global economic growth. Further, concerns over US interest rates and the US-China trade war too......

Copper futures end tad lower on trade war concerns

Copper futures ended marginally lower on Monday on account of lingering trade war concerns between the United States and the world's top industrial metals consumer China.Copper futures for December delivery......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......